Although the interaction between TIM-3 and HMGB1 is not well understood, it has been reported that HMGB1 binding to TIM-3 on DCs impairs the transport of tumor-derived nucleic acids to the endosome (Figure 3B), thereby inhibiting the pattern recognition receptor (PRR)-mediated immune response [178]. This evidence concerns the gene HAVCR2 and neoplasm.